Beschreibung
Atherosclerosis is a multifactorial vascular inflammatory disease which is one of top most common cause of deaths around worldwide. Implementing Bioinformatics tools, phospho-MurNAc-pentapeptide translocase (MraY) was identified as one of the crucial drug targets against eleven pathogens causing atherosclerosis. MraY is an essential enzyme membrane which plays a crucial role in catalyzing the essential step of bacterial cell wall biosynthesis in Gram-negative bacteria. The enzyme MraY mainly involves in the peptidoglycan biosynthesis which is unique and important for the survival of pathogens. Therefore, by blocking MraY function with lead 1 would dissolve the structural integrity, flexibility and rigidity of the cell wall and expose the pathogens to osmotic lysis and hinders the proliferation of eleven pathogens causing atherosclerosis. Hence, lead 1 will provide a framework for developing new antagonists against the eleven pathogens causing atherosclerosis.
Autorenporträt
MSc (Gold Medalist) & PhD Bioinformatics, at Sri Venkateswara Institute of Medical Sciences (SVIMS) Tirupati, worked as DBT Trainee, DST-INSPIRE Jr & Sr Research Fellow with 51 Research papers/abstracts published in national and international journals/conferences. Awarded with 8 Best Paper/Poster. Presently working as Scientist at ICGEB, Delhi.
Herstellerkennzeichnung:
OmniScriptum SRL
Str. Armeneasca 28/1, office 1
2012 Chisinau
MD
E-Mail: info@omniscriptum.com
![Produktbild: [Set Computational Drug Discovery + Computational Drug Delivery]](http://medien.umbreitkatalog.de/bildzentrale/978/311/125/3480.jpg)
